Guardion Health Sciences GHSI shares are trading higher on Monday after the company announced an investigator-initiated clinical trial of its Lumega-Z nutritional product.
Guardion Health Sciences is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Lumega-Z, is a micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment.
Guardion Health Sciences shares traded up 9.94% to 22 cents on Monday at the time of publication. The stock has a 52-week high of 74 cents and a 52-week low of 16 cents.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
